➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
McKinsey
Colorcon
Harvard Business School
AstraZeneca

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FLECAINIDE ACETATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for FLECAINIDE ACETATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00189319 To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation Completed MEDA Pharma GmbH & Co. KG Phase 4 2003-09-01 The purpose of this study is to evaluate the management of paroxysmal atrial fibrillation with controlled release flecainide on patient's quality of life.
NCT03539302 INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT) Recruiting InCarda Therapeutics Australia Pty Ltd. Phase 2 2018-05-29 The study consists of 2 parts (Part A and Part B). Part A has an open-label, randomized, multi center design to evaluate the feasibility of administration of inhaled flecainide in two dosing regimens. Part B has a randomized, double-blind, parallel group, placebo-controlled, multi center design to evaluate the safety (including tolerability) and efficacy of inhaled flecainide compared to matched placebo in two dosing regimens.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for FLECAINIDE ACETATE

Condition Name

Condition Name for FLECAINIDE ACETATE
Intervention Trials
Paroxysmal Atrial Fibrillation (PAF) 1
Atrial Fibrillation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for FLECAINIDE ACETATE
Intervention Trials
Atrial Fibrillation 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for FLECAINIDE ACETATE

Trials by Country

Trials by Country for FLECAINIDE ACETATE
Location Trials
Netherlands 1
Belgium 1
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for FLECAINIDE ACETATE

Clinical Trial Phase

Clinical Trial Phase for FLECAINIDE ACETATE
Clinical Trial Phase Trials
Phase 4 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for FLECAINIDE ACETATE
Clinical Trial Phase Trials
Recruiting 1
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for FLECAINIDE ACETATE

Sponsor Name

Sponsor Name for FLECAINIDE ACETATE
Sponsor Trials
InCarda Therapeutics Australia Pty Ltd. 1
MEDA Pharma GmbH & Co. KG 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for FLECAINIDE ACETATE
Sponsor Trials
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Mallinckrodt
AstraZeneca
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.